Abstract
dc:description.abstractIndolamine, 2, 3 dioxygenase (IDO-1) is a key rate limiting enzyme in the synthesis of kynurenine from tryptophan. IDO-1 is expressed mostly in endothelium, vascular smooth muscle cells and other organ systems. Previous work has shown IDO-1 is an important regulator of thrombosis in chronic kidney disease. Indoxyl sulfate, a uremic solute retained in patients of CKD, upregulates IDO-1 expression. We hypothesized that indoxyl sulfate (IS) suppresses IDO-1 ubiquitination and degradation. Here we show that IS, at the levels found in CKD patients, upregulates IDO-1. IS increases the half-life of IDO-1, suggesting an increase in stability. Screening of putative E3 ligases showed that F-box/WD Repeat-Containing Protein 4 (FBXW4), a Skp, Cullen, F-box containing complex (SCF) E3 ligase, interacts with IDO-1, downregulates IDO-1 protein expression, and shortens the half-life of IDO-1. This effect is mitigated in the presence of IS. This data suggests that FBXW4 is a candidate E3 ligase for IDO-1 and that IS may mediate its regulation on IDO-1 through FBXW4. This body of work for the first time shows a novel E3 ligase for IDO-1, especially in the context of the uremic milieu.
Degree
thesis:*- Name thesis:degree_name
- Master of Science
- Level thesis:degree_level
- masters
- Discipline thesis:degree_discipline
- Medical Sciences
- Grantor
- Boston University
- Year dc:date.issued
- 2023
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Wu Wong, David Jasen
- Advisor dc:contributor.advisor
-
- Chitalia, Vipul
Subjects
dc:subject × 1Rights
- Language dc:language.iso
- en_US
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- https://hdl.handle.net/2144/48418